{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:28:24Z","timestamp":1790947704093,"version":"4.1.0"},"reference-count":224,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/IA\/4468"],"award-info":[{"award-number":["16\/IA\/4468"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Immunization with current acellular pertussis (aP) vaccines protects against severe pertussis, but immunity wanes rapidly after vaccination and these vaccines do not prevent nasal colonization with Bordetella pertussis. Studies in mouse and baboon models have demonstrated that Th1 and Th17 responses are integral to protective immunity induced by previous infection with B. pertussis and immunization with whole cell pertussis (wP) vaccines. Mucosal Th17 cells, IL-17 and secretory IgA (sIgA) are particularly important in generating sustained sterilizing immunity in the nasal cavity. Current aP vaccines induce potent IgG and Th2-skewed T cell responses but are less effective at generating Th1 and Th17 responses and fail to prime respiratory tissue-resident memory T (TRM) cells, that maintain long-term immunity at mucosal sites. In contrast, a live attenuated pertussis vaccine, pertussis outer membrane vesicle (OMV) vaccines or aP vaccines formulated with novel adjuvants do induce cellular immune responses in the respiratory tract, especially when delivered by the intranasal route. An increased understanding of the mechanisms of sustained protective immunity, especially the role of respiratory TRM cells, will facilitate the development of next generation pertussis vaccines that not only protect against pertussis disease, but prevent nasal colonization and transmission of B. pertussis.<\/jats:p>","DOI":"10.3390\/vaccines8040621","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T10:14:22Z","timestamp":1603275262000},"page":"621","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-2468","authenticated-orcid":false,"given":"Caitl\u00edn N\u00ed","family":"Chasaide","sequence":"first","affiliation":[{"name":"School of Biochemistry and Immunology, Trinity College Dublin, 2, D02 PN40 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingston H.G.","family":"Mills","sequence":"additional","affiliation":[{"name":"School of Biochemistry and Immunology, Trinity College Dublin, 2, D02 PN40 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/jit639","article-title":"Pertussis Pathogenesis\u2014What We Know and What We Don\u2019t Know","volume":"209","author":"Hewlett","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/jcm.32.11.2851-2853.1994","article-title":"Unexpected isolation of Bordetella pertussis from a blood culture","volume":"32","author":"Janda","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1542\/peds.68.5.650","article-title":"Nature and Rates of Adverse Reactions Associated with DTP and DT Immunizations in Infants and Children","volume":"68","author":"Cody","year":"1981","journal-title":"Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: Adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1073\/pnas.1321360111","article-title":"Unraveling the challenges of pertussis","volume":"111","author":"Edwards","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1586\/14760584.2014.930667","article-title":"Bordetella pertussis fimbriae (Fim): Relevance for vaccines","volume":"13","author":"Gorringe","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: Overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"World Health Organization (2016). Pertussis vaccines: WHO position paper, August 2015\u2014Recommendations. Vaccine, 34, 1423\u20131425.","DOI":"10.1016\/j.vaccine.2015.10.136"},{"key":"ref_10","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines  recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/infdis\/jit592","article-title":"Pertussis Vaccine Trials in the 1990s","volume":"209","author":"Lambert","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/22221751.2018.1564630","article-title":"Immunization with whole cell but not acellular pertussis vaccines primes CD4 T RM cells that sustain protective immunity against nasal colonization with Bordetella pertussis","volume":"8","author":"Wilk","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ross, P.J., Sutton, C.E., Higgins, S., Allen, A.C., Walsh, K., Misiak, A., Lavelle, E.C., McLoughlin, R.M., and Mills, K.H.G. (2013). Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003264"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coi.2019.03.006","article-title":"Pertussis vaccines and protective immunity","volume":"59","author":"Kapil","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.vaccine.2017.03.029","article-title":"Country-level predictors of vaccination coverage and inequalities in Gavi-supported countries","volume":"35","author":"Arsenault","year":"2017","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1093\/cid\/ciw530","article-title":"Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income Countries","volume":"63","author":"Duclos","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/S1473-3099(18)30646-7","article-title":"PERISCOPE: Road towards effective control of pertussis","volume":"19","author":"Diavatopoulos","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1542\/peds.2012-3836","article-title":"Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers","volume":"131","author":"Klein","year":"2013","journal-title":"Pediatrics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.2012.6364","article-title":"Number and order of whole cell pertussis vaccines in infancy and disease protection","volume":"308","author":"Sheridan","year":"2012","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children","volume":"367","author":"Klein","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jpeds.2012.05.041","article-title":"California Pertussis Epidemic, 2010","volume":"161","author":"Winter","year":"2012","journal-title":"J. Pediatr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e20153326","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap Effectiveness in Adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cid\/ciu788","article-title":"Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage","volume":"60","author":"Martin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/molbev\/msq245","article-title":"Insight into Evolution of Bordetella pertussis from Comparative Genomic Analysis: Evidence of Vaccine-Driven Selection","volume":"28","author":"Octavia","year":"2010","journal-title":"Mol. Biol. Evol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1016\/j.vaccine.2015.09.064","article-title":"Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model","volume":"33","author":"Safarchi","year":"2015","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/593682","article-title":"Bordetella pertussis Respiratory Infection in Children Is Associated with Preferential Activation of Type 1 T Helper Cells","volume":"175","author":"Ryan","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1084\/jem.186.11.1843","article-title":"Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes","volume":"186","author":"Mahon","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1128\/CVI.00449-15","article-title":"Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis","volume":"23","author":"Warfel","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4049\/jimmunol.1602051","article-title":"Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussis","volume":"199","author":"Wilk","year":"2017","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41385-018-0080-x","article-title":"Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells","volume":"11","author":"Allen","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41385-018-0073-9","article-title":"IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine","volume":"11","author":"Solans","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Althouse, B.M., and Scarpino, S.V. (2015). Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med., 13.","DOI":"10.1186\/s12916-015-0382-8"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Choi, Y.H., Campbell, H., Amirthalingam, G., van Hoek, A.J., and Miller, E. (2016). Investigating the pertussis resurgence in England and Wales, and options for future control. BMC Med., 14.","DOI":"10.1186\/s12916-016-0665-8"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"a029454","DOI":"10.1101\/cshperspect.a029454","article-title":"What is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines","volume":"9","author":"Burdin","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"ftv067","DOI":"10.1093\/femspd\/ftv067","article-title":"Roads to the development of improved pertussis vaccines paved by immunology","volume":"73","author":"Brummelman","year":"2015","journal-title":"Pathog. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.20021153","article-title":"Role of adhesin release for mucosal colonization by a bacterial pathogen","volume":"197","author":"Coutte","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/mpat.2002.0517","article-title":"Bordetella pertussis infection of human respiratory epithelial cells up-regulates intercellular adhesion molecule-1 expression: Role of filamentous hemagglutinin and pertussis toxin","volume":"33","author":"Ishibashi","year":"2002","journal-title":"Microb. Pathog."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.4049\/jimmunol.177.9.5861","article-title":"Accelerated Antigen Sampling and Transport by Airway Mucosal Dendritic Cells following Inhalation of a Bacterial Stimulus","volume":"177","author":"Jahnsen","year":"2006","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/IAI.01578-06","article-title":"Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract","volume":"75","author":"Carbonetti","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/mi.2014.125","article-title":"A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis","volume":"8","author":"Bernard","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/acs.jproteome.5b00258","article-title":"Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity","volume":"14","author":"Raeven","year":"2015","journal-title":"J. Proteome Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1183\/09031936.01.18040692","article-title":"Lung dendritic cells and host immunity to infection","volume":"18","author":"Lambrecht","year":"2001","journal-title":"Eur. Respir. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.171.6.3119","article-title":"Toll-Like Receptor 4-Mediated Innate IL-10 Activates Antigen-Specific Regulatory T Cells and Confers Resistance to Bordetella pertussis by Inhibiting Inflammatory Pathology","volume":"171","author":"Higgins","year":"2003","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.0900169","article-title":"CD11c + CD8\u03b1 + Dendritic Cells Promote Protective Immunity to Respiratory Infection with Bordetella pertussis","volume":"183","author":"Dunne","year":"2009","journal-title":"J. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4049\/jimmunol.1601024","article-title":"IL-17\u2013Producing Innate and Pathogen-Specific Tissue Resident Memory \u03b3\u03b4 T Cells Expand in the Lungs of Bordetella pertussis\u2013Infected Mice","volume":"198","author":"Misiak","year":"2016","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/IAI.01150-08","article-title":"Role of neutrophils in response to Bordetella pertussis infection in mice","volume":"77","author":"Andreasen","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Boehm, D.T., Varney, M.E., Wong, T.Y., Nowak, E.S., Sen-Kilic, E., Hall, J., Bradford, S.D., DeRoos, K., Bevere, J., and Epperly, M. (2019). Characterizing the innate and adaptive responses of immunized mice to Bordetella pertussis infection using in vivo imaging and transcriptomic analysis. bioRxiv.","DOI":"10.1101\/674408"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/eji.200425092","article-title":"Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells","volume":"34","author":"Byrne","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1128\/iai.65.12.4904-4908.1997","article-title":"Role of gamma interferon in natural clearance of Bordetella pertussis infection","volume":"65","author":"Barbic","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri3210","article-title":"Interferon-inducible effector mechanisms in cell-autonomous immunity","volume":"12","author":"MacMicking","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/mi.2012.54","article-title":"Immunity to the respiratory pathogen Bordetella pertussis","volume":"5","author":"Higgs","year":"2012","journal-title":"Mucosal Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/iai.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: Role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/mi.2012.117","article-title":"Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates","volume":"6","author":"Warfel","year":"2013","journal-title":"Mucosal Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular Helper T Cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/IAI.68.7.3873-3877.2000","article-title":"Antigen-Specific Responses to Diphtheria-Tetanus-Acellular Pertussis Vaccine in Human Infants Are Initially Th2 Polarized","volume":"68","author":"Rowe","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cellimm.2016.05.002","article-title":"Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood","volume":"304\u2013305","author":"Bancroft","year":"2016","journal-title":"Cell. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis","volume":"334","author":"Greco","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.meegid.2016.02.032","article-title":"Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence","volume":"40","author":"Sealey","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gambhir, M., Clark, T.A., Cauchemez, S., Tartof, S.Y., Swerdlow, D.L., and Ferguson, N.M. (2015). A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput. Biol., 11.","DOI":"10.1371\/journal.pcbi.1004138"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/CVI.00469-09","article-title":"Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis","volume":"17","author":"Cherry","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1016\/j.vaccine.2011.07.055","article-title":"Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children","volume":"29","author":"Hendrikx","year":"2011","journal-title":"Vaccine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection againstBordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1988.tb00739.x","article-title":"The Role of Helper T Cell Products in Mouse B Cell Differentiation and Isotype Regulation","volume":"102","author":"Coffman","year":"1988","journal-title":"Immunol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0008-8749(91)90257-C","article-title":"IFN-\u03b3 enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: Implications for the role of IFN-\u03b3 in class switching","volume":"135","author":"Bossie","year":"1991","journal-title":"Cell. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molimm.2011.11.006","article-title":"Possible allelic structure of IgG2a and IgG2c in mice","volume":"50","author":"Zhang","year":"2012","journal-title":"Mol. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-3083.1989.tb01221.x","article-title":"Regulation of IgG1 and IgE Synthesis by Interleukin 4 in Mouse B Cells","volume":"30","author":"Moon","year":"1989","journal-title":"Scand. J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/319266","article-title":"Targeting to Fc\u03b3 Receptors, But Not CR3 (CD11b\/CD18), Increases Clearance of Bordetella pertussis","volume":"183","author":"Hellwig","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG Subclasses and Allotypes: From Structure to Effector Functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1172\/JCI135020","article-title":"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans","volume":"130","author":"Lin","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/jcm.20.2.167-170.1984","article-title":"Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells","volume":"20","author":"Tuomanen","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1128\/IAI.69.8.4846-4850.2001","article-title":"Immunoglobulin A-mediated protection against Bordetella pertussis infection","volume":"69","author":"Hellwig","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mi.2016.28","article-title":"Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses","volume":"10","author":"Christensen","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting Edge: Lung Mucosal Th17-Mediated Responses Induce Polymeric Ig Receptor Expression by the Airway Epithelium and Elevate Secretory IgA Levels","volume":"182","author":"Jaffar","year":"2009","journal-title":"J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/iai.61.8.3190-3198.1993","article-title":"Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity","volume":"61","author":"Redhead","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1084\/jem.20090494","article-title":"Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN","volume":"206","author":"Nagamatsu","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: New perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20011288","article-title":"Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis","volume":"195","author":"McGuirk","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"795958","DOI":"10.1155\/2012\/795958","article-title":"Both CD4+ and CD8+ lymphocytes participate in the IFN-\u03b3 response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults","volume":"2012","author":"Dirix","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Raeven, R.H.M., Brummelman, J., Pennings, J.L.A., Nijst, O.E.M., Kuipers, B., Blok, L.E.R., Helm, K., van Riet, E., Jiskoot, W., and van Els, C.A.C.M. (2014). Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104548"},{"key":"ref_84","first-page":"7134168","article-title":"Neonatal Immunity to Bordetella pertussis Infection and Current Prevention Strategies","volume":"2019","author":"Rodrigues","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1074\/jbc.M609501200","article-title":"The human IL-13 locus in neonatal CD4+ T cells is refractory to the acquisition of a repressive chromatin architecture","volume":"282","author":"Webster","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.4049\/jimmunol.1302539","article-title":"CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program","volume":"192","author":"Hebel","year":"2014","journal-title":"J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/NIB-140078","article-title":"Epigenetic Regulation of the Th2 Locus in Fetal and Neonatal T Cells","volume":"5","author":"Adkins","year":"2014","journal-title":"Adv. Neuroimmune Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.170.3.1504","article-title":"Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell Responses","volume":"170","author":"Mascart","year":"2003","journal-title":"J. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2010.11.002","article-title":"The role of Th17 cytokines in primary mucosal immunity","volume":"21","author":"Kolls","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/infdis\/jix254","article-title":"Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons against Bordetella pertussis Disease and Infection","volume":"216","author":"Locht","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.4049\/jimmunol.177.11.7980","article-title":"TLR4 Mediates Vaccine-Induced Protective Cellular Immunity to Bordetella pertussis: Role of IL-17-Producing T Cells","volume":"177","author":"Higgins","year":"2006","journal-title":"J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.4049\/jimmunol.1000105","article-title":"Inflammasome Activation by Adenylate Cyclase Toxin Directs Th17 Responses and Protection against Bordetella pertussis","volume":"185","author":"Dunne","year":"2010","journal-title":"J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1172\/JCI121309","article-title":"Th1\/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters","volume":"128","author":"Babor","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2018.00051","article-title":"Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles","volume":"9","author":"Hendrikx","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: Local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ni.1718","article-title":"Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus","volume":"10","author":"Gebhardt","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20090858","article-title":"Dynamic T cell migration program provides resident memory within intestinal epithelium","volume":"207","author":"Masopust","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.celrep.2017.08.078","article-title":"Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites","volume":"20","author":"Kumar","year":"2017","journal-title":"Cell Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.4049\/jimmunol.1402256","article-title":"Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention","volume":"194","author":"Mackay","year":"2015","journal-title":"J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.4049\/jimmunol.1102243","article-title":"Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection","volume":"187","author":"Teijaro","year":"2011","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/mi.2015.52","article-title":"Divergent behavior of mucosal memory T cells","volume":"8","author":"Pham","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1254536","article-title":"Resident memory CD8 T cells trigger protective innate and adaptive immune responses","volume":"346","author":"Schenkel","year":"2014","journal-title":"Science"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2568","article-title":"Sensing and alarm function of resident memory CD8+ T cells","volume":"14","author":"Schenkel","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/mi.2014.87","article-title":"A major population of mucosal memory CD4+ T cells, coexpressing IL-18R\u03b1 and DR3, display innate lymphocyte functionality","volume":"8","author":"Holmkvist","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.166.4.2348","article-title":"Direct Analysis of the Dynamics of the Intestinal Mucosa CD8 T Cell Response to Systemic Virus Infection","volume":"166","author":"Masopust","year":"2001","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1074-7613(03)00112-2","article-title":"Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia","volume":"18","author":"Khanna","year":"2003","journal-title":"Immunity"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1257530","article-title":"T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells","volume":"346","author":"Iijima","year":"2014","journal-title":"Science"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/mi.2017.46","article-title":"Airway T cells protect against RSV infection in the absence of antibody","volume":"11","author":"Kinnear","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e85832","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection","volume":"1","author":"Zens","year":"2016","journal-title":"JCI Insight"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.1402975","article-title":"Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-\u03b3 Production","volume":"195","author":"McMaster","year":"2015","journal-title":"J. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e20200218","DOI":"10.1084\/jem.20200218","article-title":"Influenza infection fortifies local lymph nodes to promote lung-resident heterosubtypic immunity","volume":"218","author":"Paik","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/mi.2017.43","article-title":"Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia","volume":"11","author":"Smith","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1016\/j.celrep.2019.11.103","article-title":"Bystander Activation of Pulmonary Trm Cells Attenuates the Severity of Bacterial Pneumonia by Enhancing Neutrophil Recruitment","volume":"29","author":"Ge","year":"2019","journal-title":"Cell Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/mi.2016.70","article-title":"Subunit vaccine H56\/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung","volume":"10","author":"Woodworth","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1016\/j.vaccine.2018.07.035","article-title":"Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4+ T cell population following BCG immunisation","volume":"36","author":"Bull","year":"2018","journal-title":"Vaccine"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Mielcarek, N., Debrie, A.-S., Raze, D., Bertout, J., Rouanet, C., Younes, A.B., Creusy, C., Engle, J., Goldman, W.E., and Locht, C. (2006). Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog., 2.","DOI":"10.1371\/journal.ppat.0020065"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Thorstensson, R., Trollfors, B., Al-Tawil, N., Jahnmatz, M., Bergstrom, J., Ljungman, M., Torner, A., Wehlin, L., Van Broekhoven, A., and Bosman, F. (2014). A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0083449"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1016\/j.vaccine.2010.08.017","article-title":"Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1","volume":"28","author":"Feunou","year":"2010","journal-title":"Vaccine"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Feunou Feunou, P., Bertout, J., and Locht, C. (2010). T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against Parapertussis. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010178"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CVI.00371-10","article-title":"A Live, Attenuated Bordetella pertussis Vaccine Provides Long-Term Protection against Virulent Challenge in a Murine Model","volume":"18","author":"Skerry","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.1901102","article-title":"Early Protection against Pertussis Induced by Live Attenuated Bordetella pertussis BPZE1 Depends on TLR4","volume":"203","author":"Debrie","year":"2019","journal-title":"J. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.4049\/jimmunol.1003765","article-title":"Attenuated Bordetella pertussis Vaccine Candidate BPZE1 Promotes Human Dendritic Cell CCL21-Induced Migration and Drives a Th1\/Th17 Response","volume":"186","author":"Fedele","year":"2011","journal-title":"J. Immunol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from Gram-negative bacteria: Biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"38240","DOI":"10.1038\/srep38240","article-title":"Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine","volume":"6","author":"Raeven","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1016\/j.vaccine.2008.07.004","article-title":"Outer membrane vesicles as acellular vaccine against pertussis","volume":"26","author":"Roberts","year":"2008","journal-title":"Vaccine"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fcimb.2019.00125","article-title":"A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains","volume":"9","author":"Zurita","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1016\/j.vaccine.2016.04.079","article-title":"Characterization of the immune response induced by pertussis OMVs-based vaccine","volume":"34","author":"Bottero","year":"2016","journal-title":"Vaccine"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.vaccine.2013.12.048","article-title":"Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes","volume":"32","author":"Gaillard","year":"2014","journal-title":"Vaccine"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.vaccine.2010.12.068","article-title":"Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate","volume":"29","author":"Asensio","year":"2011","journal-title":"Vaccine"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-5728(02)00468-X","article-title":"IL-1\u03b2-dependent neurological effects of the whole cell pertussis vaccine: A role for IL-1-associated signalling components in vaccine reactogenicity","volume":"136","author":"Armstrong","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/mi.2017.81","article-title":"Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination","volume":"11","author":"Raeven","year":"2018","journal-title":"Mucosal Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1038\/s41598-020-63998-2","article-title":"Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses","volume":"10","author":"Raeven","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00717-13","article-title":"Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States","volume":"21","author":"Pawloski","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1508.081511","article-title":"Bordetella pertussis strains with increased toxin production associated with pertussis resurgence","volume":"15","author":"Mooi","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3201\/eid2202.151332","article-title":"Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin","volume":"22","author":"Williams","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1016\/j.vaccine.2009.07.074","article-title":"First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin","volume":"27","author":"Bouchez","year":"2009","journal-title":"Vaccine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1700832","DOI":"10.2807\/1560-7917.ES.2019.24.7.1700832","article-title":"Pertactin-deficient Bordetella pertussis isolates: Evidence of increased circulation in Europe, 1998 to 2015","volume":"24","author":"Barkoff","year":"2019","journal-title":"Euro Surveill."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Miyaji, Y., Otsuka, N., Toyoizumi-Ajisaka, H., Shibayama, K., and Kamachi, K. (2013). Genetic Analysis of Bordetella pertussis Isolates from the 2008\u20132010 Pertussis Epidemic in Japan. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077165"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00430-017-0524-z","article-title":"Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance","volume":"207","author":"Dorji","year":"2018","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1099\/mic.0.058941-0","article-title":"The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA","volume":"158","author":"Decker","year":"2012","journal-title":"Microbiology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2958.1996.5231057.x","article-title":"Phosphorylation-dependent binding of BvgA to the upstream region of the cyaA gene of Bordetella pertussis","volume":"20","author":"Karimova","year":"1996","journal-title":"Mol. Microbiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.4049\/jimmunol.181.8.5587","article-title":"Adenylate Cyclase Toxin Subverts Phagocyte Function by RhoA Inhibition and Unproductive Ruffling","volume":"181","author":"Kamanova","year":"2008","journal-title":"J. Immunol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/infdis\/163.1.135","article-title":"Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis","volume":"163","author":"Arciniega","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1099\/00222615-32-3-173","article-title":"Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination","volume":"32","author":"Farfel","year":"1990","journal-title":"J. Med. Microbiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1574-695X.1993.tb00345.x","article-title":"Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera","volume":"6","author":"Arciniega","year":"1993","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0882-4010(89)90040-5","article-title":"Bordetella adenylate cyclase is a virulent associated factor and an immunoprotective antigen","volume":"7","author":"Guiso","year":"1989","journal-title":"Microb. Pathog."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1574-695X.1999.tb01248.x","article-title":"Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice","volume":"23","author":"Hormozi","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0882-4010(91)90038-C","article-title":"Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization","volume":"11","author":"Guiso","year":"1991","journal-title":"Microb. Pathog."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0882-4010(92)90057-U","article-title":"Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection","volume":"12","author":"Khelef","year":"1992","journal-title":"Microb. Pathog."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1128\/IAI.01104-06","article-title":"Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model","volume":"74","author":"Cheung","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1365-2958.2004.04227.x","article-title":"Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis","volume":"53","author":"Gray","year":"2004","journal-title":"Mol. Microbiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/S0021-9258(18)89054-8","article-title":"Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration","volume":"260","author":"Hanski","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1074\/jbc.M114.585281","article-title":"The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies","volume":"290","author":"Wang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e00857-17","DOI":"10.1128\/IAI.00857-17","article-title":"Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice","volume":"86","author":"Boehm","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/IAI.69.5.3067-3072.2001","article-title":"BrkA Protein of Bordetella pertussis Inhibits the Classical Pathway of Complement after C1 Deposition","volume":"69","author":"Barnes","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1016\/j.vaccine.2008.06.017","article-title":"Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model","volume":"26","author":"Marr","year":"2008","journal-title":"Vaccine"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1074\/mcp.RA117.000045","article-title":"Outer Membrane Vesicles (OMV)-based and Proteomics-driven Antigen Selection Identifies Novel Factors Contributing to Bordetella pertussis Adhesion to Epithelial Cells","volume":"17","author":"Gasperini","year":"2018","journal-title":"Mol. Cell. Proteom."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"de Gouw, D., de Jonge, M.I., Hermans, P.W.M., Wessels, H.J.C.T., Zomer, A., Berends, A., Pratt, C., Berbers, G.A., Mooi, F.R., and Diavatopoulos, D.A. (2014). Proteomics-Identified Bvg-Activated Autotransporters Protect against Bordetella pertussis in a Mouse Model. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105011"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine Adjuvants: Putting Innate Immunity to Work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"ref_165","first-page":"789","article-title":"Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: Follow-up evaluation","volume":"81","author":"Baraff","year":"1988","journal-title":"Pediatrics"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"McKee, A.S., MacLeod, M.K.L., Kappler, J.W., and Marrack, P. (2010). Immune mechanisms of protection: Can adjuvants rise to the challenge?. BMC Biol., 8.","DOI":"10.1186\/1741-7007-8-37"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Villa, P., and Ghezzi, P. (2004). Animal Models of Endotoxic Shock. Tumor Necrosis Factor, Humana Press.","DOI":"10.1385\/1-59259-771-8:199"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.1700290106","article-title":"Immunological notes. XVII\u2013XXIV","volume":"29","author":"Glenny","year":"1926","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.201747150","article-title":"The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses","volume":"48","author":"Oleszycka","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.1700340214","article-title":"Rate of disappearance of diphtheria toxoid injected into rabbits and guinea - pigs: Toxoid precipitated with alum","volume":"34","author":"Glenny","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2105\/AJPH.25.3.298","article-title":"Some Observations on the Use of Alum Precipitated Diphtheria Toxoid","volume":"25","author":"Harrison","year":"1935","journal-title":"Am. J. Public Health Nation\u2019s Health"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.vaccine.2004.07.050","article-title":"Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro","volume":"23","author":"Morefield","year":"2005","journal-title":"Vaccine"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","article-title":"Cutting Edge: Inflammasome Activation by Alum and Alum\u2019s Adjuvant Effect Are Mediated by NLRP3","volume":"181","author":"Li","year":"2008","journal-title":"J. Immunol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.4049\/jimmunol.178.8.5271","article-title":"Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release","volume":"178","author":"Li","year":"2007","journal-title":"J. Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/eji.200838549","article-title":"The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity","volume":"38","author":"Franchi","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1002\/eji.201242372","article-title":"The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses","volume":"42","author":"Mori","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Banus, S., Stenger, R.M., Gremmer, E.R., Dormans, J.A.M.A., Mooi, F.R., Kimman, T.G., and Vandebriel, R.J. (2008). The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. BMC Immunol., 9.","DOI":"10.1186\/1471-2172-9-21"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.micinf.2013.06.010","article-title":"Toll-like receptor 4 orchestrates neutrophil recruitment into airways during the first hours of Bordetella pertussis infection","volume":"15","author":"Moreno","year":"2013","journal-title":"Microbes Infect."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000315915","article-title":"Endotoxins and Other Sepsis Triggers","volume":"Volume 167","author":"Opal","year":"2010","journal-title":"Endotoxemia and Endotoxin Shock"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/14760584.2013.811204","article-title":"Adjuvants containing natural and synthetic Toll-like receptor 4 ligands","volume":"12","author":"Ireton","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11591760-000000000-00000","article-title":"Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach","volume":"25","author":"Morel","year":"2011","journal-title":"BioDrugs"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.vaccine.2014.10.078","article-title":"Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination","volume":"33","author":"Vandepapeliere","year":"2015","journal-title":"Vaccine"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/CVI.00074-07","article-title":"Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice","volume":"14","author":"Geurtsen","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.vaccine.2015.01.063","article-title":"Modulation of the CD4+ T cell response after acellular pertussis vaccination in the presence of TLR4 ligation","volume":"33","author":"Brummelman","year":"2015","journal-title":"Vaccine"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"25064","DOI":"10.1038\/srep25064","article-title":"Transcriptome signature for dampened Th2 dominance in acellular pertussis vaccine-induced CD4+ T cell responses through TLR4 ligation","volume":"6","author":"Brummelman","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2008.12.008","article-title":"Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists","volume":"61","author":"Vollmer","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.2001.tb00535.x","article-title":"CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice","volume":"32","author":"Weeratna","year":"2001","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4161\/hv.22755","article-title":"A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis","volume":"9","author":"Asokanathan","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1016\/j.vaccine.2004.09.041","article-title":"A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1\/Th2 immune response in diphtheria\u2013tetanus\u2013pertussis vaccine","volume":"23","author":"Sugai","year":"2005","journal-title":"Vaccine"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/jir.2017.0060","article-title":"Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella pertussis in BALB\/c Mice","volume":"38","author":"Bakhshaei","year":"2018","journal-title":"J. Interf. Cytokine Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"29063","DOI":"10.1038\/srep29063","article-title":"Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines","volume":"6","author":"Buonsanti","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Mancini, F., Monaci, E., Lofano, G., Torre, A., Bacconi, M., Tavarini, S., Sammicheli, C., Arcidiacono, L., Galletti, B., and Laera, D. (2016). One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147767"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1073\/pnas.1424924112","article-title":"Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus","volume":"112","author":"Bagnoli","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"263ra160","DOI":"10.1126\/scitranslmed.3009980","article-title":"Rational design of small molecules as vaccine adjuvants","volume":"6","author":"Wu","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.vaccine.2017.08.009","article-title":"Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model","volume":"35","author":"Misiak","year":"2017","journal-title":"Vaccine"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/mi.2014.93","article-title":"A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine","volume":"8","author":"Dunne","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molcel.2013.07.004","article-title":"The cGAS-STING Pathway for DNA Sensing","volume":"51","author":"Xiao","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni.2491","article-title":"STING and the innate immune response to nucleic acids in the cytosol","volume":"14","author":"Burdette","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","article-title":"STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci. Signal."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Elahi, S., Van Kessel, J., Kiros, T.G., Strom, S., Hayakawa, Y., Hyodo, M., Babiuk, L.A., and Gerdts, V. (2014). c-di-GMP enhances protective innate immunity in a murine model of pertussis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109778"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","article-title":"More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis","volume":"10","author":"Gschwandtner","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1002\/eji.1830241249","article-title":"Induction of natural killer cell migration by monocyte chemotactic protein\u22121, \u22122 and \u22123","volume":"24","author":"Allavena","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1128\/IAI.00895-08","article-title":"Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice","volume":"76","author":"Andreasen","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/eji.201445132","article-title":"TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN","volume":"45","author":"Temizoz","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0264-410X(00)00433-3","article-title":"Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: Effect of formulation and route of immunization on induction of Th1 and Th2 cells","volume":"19","author":"Conway","year":"2001","journal-title":"Vaccine"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ebiom.2017.12.004","article-title":"T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties","volume":"27","author":"Moguche","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Krammer, F. (2020). SARS-CoV-2 vaccines in development. Nature.","DOI":"10.1038\/s41586-020-2798-3"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/cei.13287","article-title":"Novel approaches for the design, delivery and administration of vaccine technologies","volume":"196","author":"Wallis","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3389\/fimmu.2018.01860","article-title":"CD4 TRM Cells Following Infection and Immunization: Implications for More Effective Vaccine Design","volume":"9","author":"Wilk","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13285","article-title":"Mucosal vaccines and technology","volume":"196","author":"Bentley","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e01686-16","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis","volume":"7","author":"Perdomo","year":"2016","journal-title":"MBio"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41385-018-0109-1","article-title":"Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1\u2212 CD4+ T cells","volume":"12","author":"Bull","year":"2019","journal-title":"Mucosal Immunol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.celrep.2018.04.003","article-title":"STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection","volume":"23","author":"Sogi","year":"2018","journal-title":"Cell Rep."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: Adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen","volume":"174","author":"Santosuosso","year":"2005","journal-title":"J. Immunol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Gu\u00e9rin Immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J. Immunol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single Intranasal Mucosal Mycobacterium bovis BCG Vaccination Confers Improved Protection Compared to Subcutaneous Vaccination against Pulmonary Tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/CVI.00700-13","article-title":"Pulmonary Mycobacterium bovis BCG Vaccination Confers Dose-Dependent Superior Protection Compared to That of Subcutaneous Vaccination","volume":"21","author":"Aguilo","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_222","first-page":"351","article-title":"Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin","volume":"107","author":"Barclay","year":"1973","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3389\/fimmu.2018.03068","article-title":"The Role of Mucosal Immunity in Pertussis","volume":"9","author":"Solans","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/621\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:25:17Z","timestamp":1760178317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":224,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["vaccines8040621"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8040621","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]}}}